PURCHASE ORDER
Active75N98026P01477
Department of Health and Human Services › National Institutes of Health › NATIONAL INSTITUTES OF HEALTH OLAO
$350K
obligated · signed 2 months ago
MODIFICATION TO THE A11 HERV-E TCR AND T CELL PRODUCT TOIMPROVE THE THERAPEUTIC EFFICACY FOR CCRCC PATIENTS
Performance timeline
Start
Sep 15, 2026
Current end
Sep 14, 2027
Potential end
Sep 14, 2030
with all options
Loading status
Estimated start: Sep 14, 2029
LOYOLA UNIVERSITY OF CHICAGO
Contract 75N98026P01477
UEI
RFRPFMNR8LA5
Parent Company
LOYOLA UNIVERSITY OF CHICAGO
Capabilities & Certifications
Headquarters Location
Congressional District: 07
Current Obligation
$350,000
Base + Exercised Options
$350,000
Total Ceiling Value
$1,400,000
Contract Type
FIRM FIXED PRICE
NAICS
GENERAL MEDICAL AND SURGICAL HOSPITALS
PSC
SUPPORT- PROFESSIONAL: OTHER
Place of Performance
Congressional District: 07
Awarding Agency
Top-tier agency
National Institutes of Health
Sub-tier agency
NATIONAL INSTITUTES OF HEALTH OLAO
Office
Funding Agency
Top-tier agency
National Institutes of Health
Sub-tier agency
NATIONAL INSTITUTES OF HEALTH NHLBI
Office
Solicitation procedures, competition exceptions, labor standards and account totals.